ing. Am. J. Physiol. 275 (Regulatory Integrative Comp. Physiol.
44): R174–R179, 1998.
11. Fraser, K. A., and J. S. Davison. Cholecystokinin-induced c-fos 24.
expression in the rat brain stem is influenced by vagal nerve
integrity. Exp. Physiol. 77: 225–228, 1992.
12. Geary, N., D. Trace, B, McEwen, and G. P. Smith. Cyclic
estradiol replacement increases the satiety effect of CCK-8 in 25.
ovariectomized rats. Physiol. Behav. 56: 281–289, 1994.
13. Kahler, A., N. Geary, L. A. Eckel, L. A. Campfield, F. J.
Smith, and W. Langhans. Chronic administration of OB protein decreases food intake by selectively reducing meal size in 26.
male rats. Am. J. Physiol. 275 (Regulatory Integrative Comp.
Physiol. 44): R180–R185, 1998.
14. Linden, A., K. Uvnas-Moberg, G. Forsberg, I. Bednar, and 27.
P. So ̈ dersten. Involvement of cholecystokinin in food intake. II.
Lactational hyperphagia in the rat. J. Neuroendocrinol. 2: 783–
789, 1990.
15. Maffei, M., J. Halaas, E. Ravussin, R. E. Pratley, G. H. Lee, 28.
Y. Zhang, H. Fei, S. Kim, R. Lallone, S. Ranganathan, P. A.
Kern, and J. M. Friedman. Leptin levels in human and rodent:
measurement of plasma leptin and obmRNA in obese and 29.
weight-reduced subjects. Nat. Med. 1: 1155–1161, 1995.
16. Matson, C. A., M. F. Wiater, J. L. Kuijper, and D. S. Weigle. 30.
Synergy between leptin and cholecystokinin (CCK) to control
daily caloric intake. Peptides 18: 1275–1278, 1997.
17. Moran, T. H., P. J. Ameglio, G. J. Schwartz, and P. R.
McHugh. Blockade of type A, but not type B, CCK receptors
postpones satiety in rhesus monkeys. Am. J. Physiol. 265 (Regu- 31.
latory Integrative Comp. Physiol. 34): R620–R624, 1993.
18. Moran, T. H., L. F. Katz, C. R. Plata-Salaman, and G. J.
Schwartz. Disordered food intake and obesity in rats lacking
cholecystokinin A receptors. Am. J. Physiol. 274 (Regulatory
Integrative Comp. Physiol. 43): R618–R625, 1998.
19. Moran, T. H., T. K. Sawyer, D. H. Seeb, P. J. Ameglio, M. A. 32.
Lombard, and P. R. McHugh. Potent and sustained satiety
actions of a cholecystokinin octapeptide analogue. Am. J. Clin.
Nutr. 55: 286S–290S, 1992.
20. Olson, B. R., G. E Hoffman, A. F. Sved, E. M. Stricker, and
J. G. Verbalis. Cholecystokinin induces c-fos expression in
hypothalamic oxytocinergic neurons projecting to the dorsal 33.
vagal complex. Brain Res. 569: 238–248, 1992.
21. Powley, T. L., E. A. Fox, and H. R. Berthoud. Retrograde
tracer technique for assessment of selective and total subdiaphragmatic vagotomies. Am. J. Physiol. 253 (Regulatory Integrative Comp. Physiol. 22): R361–R370, 1987.
22. Raybould, H. E., R. J. Gayton, and G. J. Dockray. Mecha- 34.
nisms of action of peripherally administered cholecystokinin
octapeptide on brainstem neurons in the the rat. J. Neurosci. 8:
3018–3024, 1988.
23. Rinaman, L., J. G. Verbalis, E. M. Sricker, and G. E. 35.
Hoffman. Distribution and neurochemical phenotypes of caudal
medullary neurons activated to express c-Fos following periph-
